Latest Clinical Trials news
One in Six Patients in Phase 2 Cancer Trials Receive Drug When Eventually Approved
posted February 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
AI-Assisted Screening Tool Speeds Trial Eligibility Determination
posted February 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Tecovirimat No Aid for Time to Lesion Resolution With Mpox
posted December 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
About One-Third Eligible for Weight Loss Drugs Meet Trial Exclusion Criteria
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpeg)
Most Adults With Moderate-to-Severe Ulcerative Colitis Ineligible for RCTs 
Huge Gap Exists Between Regulatory Authorization, Clinical Validation of AI Medical Devices 
Randomized Trial of Early Vitrectomy Feasible for Postoperative Endophthalmitis .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV Related Articles
Barriers to Pediatric Cancer Clinical Trial Participation Identified 
Povorcitinib Beneficial for Moderate-to-Severe Hidradenitis Suppurativa 
Rate of Clinical Trial Failure in Head & Neck Cancer Has Grown Since 2000 
Nutritional Guidance Lacking for Adults Receiving Semaglutide, Tirzepatide Monthly Specialist Briefings
Stay Connected
